Purchase Order N0025920P0197
- Not listed
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the delivery of 8 FilmArray Torch Module Boxes and 4 FilmArray Torch Duplex Module Boxes. The $168,000 contract was awarded on June 23, 2020 with a completion date of September 23, 2020. The purchase is associated with the Coronavirus COVID-19 National Interest Action Code. Biofire Diagnostics LLC is a biotech company that...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price delivery order worth $109,512.00 to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the purchase of a kit respiratory panel IVD (in-vitro diagnostic) laboratory supply test material. This contract was awarded against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The order is in support of the Coronavirus...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, is for the supply of BIOFIRE RESPIRATORY PANELS RP2.1 with a potential value of $233,601.96. The contract was awarded by the Department of the Air Force Air Combat Command, under a Firm Fixed Price purchase order, with the place of performance at Nellis AFB, NV. This award is not designated as a set-aside. Biofire Diagnostics LLC is the leader in syndromic infectious disease testing and has...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in infectious disease testing. The $110,160.00 firm-fixed-price purchase order was issued under the VA VISN 9 network for COVID-19 panel testing using Biofire's 423738 COVID emergency testing products. No set-aside was used. Biofire Diagnostics has held numerous federal contracts with the VA,...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the provision of BIOFIRE RP2.1 RESPIRATORY PANEL COVID-19 TESTING. The contract, which does not have a set-aside designation, has a potential value of $115,425.00 and a completion date of November 30, 2021. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the supply of "FILM ARRAY 1.5 US CONFIGURATION" equipment and services. The $102,064.65 firm-fixed-price delivery order was issued by the U.S. Department of the Navy's Bureau of Medicine and Surgery. The contract is associated with Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics,...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 10 awarded a $132,640.50 firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the FILMARRAY SYSTEM. This award is part of the VA's response to the Coronavirus COVID-19 national emergency. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received multiple federal contracts as a prime contractor...
This contract award is for the FILMARRAY RESPIRATORY PANEL (RP2) TEST X50 COVID-19, valued at $201,386.50, and was issued by the Department of the Navy Bureau of Medicine and Surgery to the prime contractor Biofire Diagnostics LLC. Biofire Diagnostics is a foreign-owned, for-profit biotech company that specializes in syndromic infectious disease testing. This contract has no set-aside designation. Biofire Diagnostics has received numerous federal contract awards as a prime contractor to provide a variety of goods and services related to infectious disease testing, including molecular diagnostic testing services and products, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test kits. Major customers include the Department of Veterans Affairs, the Defense Health Agency, the Department of Health and Human Services Indian Health Service, and the Department of State. Biofire Diagnostics holds several indefinite delivery contracts and blanket purchase agreements to facilitate ongoing procurement of their products and services by these federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $201.4k | 3/27/20 |